As a start up, Kyberlife looks to our mentors for guidance and direction. Through this journey, many of our mentors who eventually became friends have trusted in Kyberlife and we sincerely thank you. Here, we'd like to take some time to introduce some of the people who believe in us.
Warm welcome to our anchor investors
From left to right: Professor/Dr. David EH Ong, Associate Professor/Dr. Jeremy Lim, and Dr. Christopher Ting
Kyberlife is excited to welcome Professor/Dr. David EH Ong, Associate Professor/Dr. Jeremy Lim, and Dr. Christopher Ting as our anchor investors of Kyberlife.
With our partnership, they bring forward their expertise in healthcare, laboratory management, and the medical industry. We are committed to build stronger bonds and network with the healthcare and scientific community with their support.
We would also like to introduce Dr Jeremy Lim as Kyberlife’s Board of Directors.
Assoc. Prof/Dr. Jeremy Lim
Dr Jeremy Lim is the Co-Founder and CEO of AMiLi , the first gut microbiome company in SEA. He is also the Director for the Leadership Institute for Global Health Transformation (LIGHT) at the NUS Saw Swee Hock School of Public Health.
Prior to AMiLi, Dr. Jeremy was the founding partner of Oliver Wyman’s health and life-science practice, VP at Fortis Healthcare Global, Director of Research & Education at Singhealth and the Executive Director for the Lien Centre for Palliative Care at Duke-NUS Medical School.
He also presently serves on the boards of charities and social enterprises which include HealthServe, Dover Park Hospice and SNTC; as well as advises Digital Health at A*STAR.
Prof/Dr. David Ong
Dr. David Ong is a Gastroenterologist at Mount Elizabeth Hospital (MT. E).
Prior to Mt. E, he served as the Head of Gastroenterology and Hepatology at the National University Hospital (NUH), which he still serves as a visiting senior consultant. At NUH, Dr. David was the Divisional Director of clinical services, Director of Risk and Value of the NUH Cluster, and Associate Chairman of the Medical Board.
He also holds an adjunct associate professorship at NUS, Department of medicine and advisor and chair of the nominal committee of the international Council; in addition of being the President of the gastroenterology Society of Singapore.
Dr. Christopher Ting
Dr. Christopher Ting is the Group CEO & Founder of Pathology Asia Holdings, SEA’s largest independent private medical laboratory provider. He is also the Group CEO of Innovative Diagnostics now known as INNOQUEST.
Prior to Innovative, he served as the Assistant head of the Biomedical Science Group at EDB Singapore, Founder & CEO of Quantum Diagnostics (MY) and the CEO of Timberland Medical Center (MY).
He also participated in the Malaysian government’s healthcare NKEA initiative.
Warm welcome to our angel investors
Kyberlife is excited to welcome Rapzo Capital, AMATAR Investments and Shaun Chua (shown below) as investors in Kyberlife’s SEED Round.
These partnership with us allowed Kyberlife to learn from their multi discipline experience in different sectors and industry such as strategy, product, corporate governance, funding management, technology, and supply chain.
Shaun Chua
Shaun is the Founder of 3F Ventures that connects the startup community with investors through its extensive network.
With a background of full stack web development and product management prior to 3F, he was in charge of Product Strategy at Mighty Jaxx and Investment Associate of the Investment Angel Syndicate, Mercatus 8.
As Kyberlife continues to grow, we welcome you to follow our journey. Thank you for believing in us, stay tuned for more!